Billionaire Profile
Ramesh Juneja
Global Rank
#1357

Image: Public domain | via Wikimedia Commons

Ramesh Juneja

CEO, Mankind Pharma
IN
Real-Time Net Worth
$2.9B
As of December 2025
Age
70
Source
Pharmaceuticals
Industry
healthcare
Citizenship
IN

Biography

Ramesh Juneja, the Chairman of Mankind Pharma, is a self-made Indian billionaire with an estimated net worth of $2.9 billion. He founded Mankind Pharma in 1995 with his brother Rajeev Juneja, leading the company to become the fourth-largest pharmaceutical company in India. Juneja's career began in 1974 as a medical representative, gaining insights that fueled his vision of providing affordable healthcare. His strategic focus on accessible medicines and innovative marketing, including the coining of popular brand names, has been key to Mankind Pharma's success. Juneja's achievements have earned him recognition, including the Entrepreneur of the Year award, and his leadership principles emphasize innovation and customer satisfaction. He has also been involved in philanthropy, supporting initiatives in healthcare and education.

Wealth Over Time

In-Depth Profile

Early Life

Ramesh C. Juneja was born on July 28, 1955, in Meerut, Uttar Pradesh, India, to a middle-class family. After completing his science graduation, he embarked on his career in the pharmaceutical industry in 1974. He began as a Medical Representative at KeePharma Ltd., traveling extensively to meet doctors and promote pharmaceutical products. He later joined Lupin Limited in 1975 and worked there for approximately eight years. During this time, he observed the need for more affordable medicines, which would later inspire his entrepreneurial journey.

Rise to Success

In 1995, Ramesh Juneja, along with his brother Rajeev Juneja, founded Mankind Pharma. The company started with a modest investment of ₹50 lakhs and a small team. Under his leadership, Mankind Pharma grew into a significant player in the Indian pharmaceutical market, becoming the fourth-largest pharmaceutical company in India. Juneja is credited with coining the names of many of the company's popular brands, demonstrating his keen understanding of market dynamics and branding. The company's initial public offering (IPO) in April 2023 marked a major milestone.

Key Business Strategies

Juneja's strategy centered on providing affordable medicines, which resonated with the Indian market. He focused on offering effective medicines at competitive prices, challenging the pricing norms within the pharmaceutical industry. His business model also emphasized a strong distribution network and a robust field force. Mankind Pharma also expanded into OTC products, including contraceptives, and introduced popular brands such as Manforce, Prega News, and Unwanted 72. The company has consistently invested in state-of-the-art manufacturing facilities and expanded into international markets.

Philanthropy

Beyond his business achievements, Ramesh Juneja is known for his philanthropic contributions. He has supported various initiatives aimed at improving access to quality healthcare and promoting education among underprivileged communities.

Career Milestones

1974

Medical Representative

Began career at KeePharma Ltd.

1975

First-line Manager

Joined Lupin Limited.

1995

Founded Mankind Pharma

Co-founded Mankind Pharma with his brother Rajeev Juneja.

2023

Mankind Pharma IPO

Mankind Pharma went public.

Philanthropy & Social Impact

Healthcare and Education

Healthcare and Education Support

Undisclosed

Supported initiatives to improve access to quality healthcare and promote education in underprivileged communities.

Business Philosophy & Leadership

Leadership Principles

Innovation in Affordable Healthcare

Prioritizing the development of affordable healthcare solutions.

Customer Satisfaction

Strong emphasis on customer satisfaction and meeting their needs.